Links & Media
In the press.
Selected coverage of the companies and the work — from cancer diagnostics to cross-border payments.
- InterVenn Biosciences Closes $201M Series C Round
- With a 'monopoly' on glycoproteomics, InterVenn raises $34M
- InterVenn raises $34M for cancer test with AI
- SF Startup Targets B2B Global Payments with Blockchain Rails
- Entrepreneur Takes On Cancer
- InterVenn raises $34M for ovarian cancer and immuno-oncology
- Filipino-led company presents easier way to detect ovarian cancer
- How InterVenn Biosciences' CEO Aldo Carrascoso is revolutionizing cancer detection
- Filipino BioTech founder changes cancer fight with AI and glycan research
- InterVenn Biosciences to make Malaysia its regional hub
- Silicon Valley-Based Filipino Founder Fighting to End Cancer
- Serial Entrepreneur: Featured Guest